A phase I study of bevacizumab (BV) plus ABT-510 in patients with advanced solid tumors

被引：0
|
作者：
Uronis, H. E. [1 ]
Bendell, J. [1 ]
Blobe, G. [1 ]
Morse, M. [1 ]
Geier, D. [1 ]
Nixon, A. [1 ]
Howard, L. [1 ]
Evans, D. [1 ]
Li, H. [1 ]
Hurwitz, H. [1 ]
机构：
[1] Duke Univ, Durham, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3541
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A phase I study of bevacizumab, everolimus and panitumumab in advanced solid tumors
    Vlahovic, Gordana
    Meadows, Kellen L.
    Uronis, Hope E.
    Morse, Michael A.
    Blobe, Gerard C.
    Riedel, Richard F.
    Zafar, S. Yousuf
    Alvarez-Secord, Angeles
    Gockerman, Jon
    Starodub, Alexander N.
    Ready, Neal E.
    Anderson, Elizabeth L.
    Bendell, Johanna C.
    Hurwitz, Herbert I.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (01) : 95 - 102
  • [22] A phase I study of bevacizumab in combination with sunitinib in advanced solid tumors
    Cooney, M. M.
    Garcia, J.
    Brell, J.
    Dreicer, R.
    Beatty, K.
    Mekhail, T.
    Bukowski, R.
    Zwiebel, J.
    Remick, S. C.
    Rini, B. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [23] Phase I study of dasatinib in combination with bevacizumab in advanced solid tumors
    Kim, G.
    Annunziata, C. M.
    Sarosy, G. A.
    Minasian, L. M.
    Prindiville, S. A.
    Zujewski, J.
    Otten, L.
    Squires, J.
    Houston, N. D.
    Kohn, E. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [24] Phase I study of enzastaurin (ENZ) and bevacizumab (BV) in patients with advanced cancer
    Resta, L. P.
    Ermisch, S.
    Collins, C.
    Nicol, S. J.
    Armstrong, D. K.
    Wang, T.
    Zhang, Z.
    Thornton, D.
    Carducci, M. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [25] Phase I Study of Bevacizumab Plus Irinotecan in Pediatric Patients with Recurrent/Refractory Solid Tumors
    Okada, Keiko
    Yamasaki, Kai
    Tanaka, Chika
    Fujisaki, Hiroyuki
    Osugi, Yuko
    Hara, Junichi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 43 (11) : 1073 - 1079
  • [26] Randomized, Phase II Study of the Thrombospondin-1-Mimetic Angiogenesis Inhibitor ABT-510 in Patients With Advanced Soft Tissue Sarcoma
    Baker, Laurence H.
    Rowinsky, Eric K.
    Mendelson, David
    Humerickhouse, Rod A.
    Knight, Raymond A.
    Qian, Jiang
    Carr, Robert A.
    Gordon, Gary B.
    Demetri, George D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (34) : 5583 - 5588
  • [27] A phase 2 study of the thrombospondin-mimetic peptide ABT-510 in patients with refractory lymphoma.
    Levine, AM
    Schwartzberg, L
    Smith, S
    Belt, R
    Knight, R
    Carlson, D
    Hippensteel, R
    Kahl, B
    BLOOD, 2005, 106 (11) : 430A - 430A
  • [28] A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors
    Uronis, Hope E.
    Jia, Jingquan
    Bendell, Johanna C.
    Howard, Leigh
    Ready, Neal A.
    Lee, Paula H.
    Starr, Mark D.
    Dellinger, Andrew
    Pang, Herbert
    Nixon, Andrew B.
    Hurwitz, Herbert I.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (02) : 343 - 352
  • [29] A phase I study of ombrabulin (O) combined with bevacizumab (B) in patients with advanced solid tumors
    Ong, Michael
    Del Conte, Gianluca
    Bahleda, Rastislav
    Mateo, Joaquin
    Damian, Silvia
    Perotti, Antonella
    Lassau, Nathalie
    Farace, Franoise
    Lovosgaldeano, Jimena
    Tunariu, Nina
    Hospitel, Marie
    Mariani, Paola
    Cohen, Patrick
    Capri, Giuseppe
    Soria, Jean-Charles
    Gianni, Luca
    Molife, L. Rhoda
    Sessa, Cristiana
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [30] A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors
    Hope E. Uronis
    Jingquan Jia
    Johanna C. Bendell
    Leigh Howard
    Neal A. Ready
    Paula H. Lee
    Mark D. Starr
    Andrew Dellinger
    Herbert Pang
    Andrew B. Nixon
    Herbert I. Hurwitz
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 343 - 352
12345